Invitation: From July 20 to July 22, 2023, Haibu invites you to Hangzhou, Zhejiang for the Second International MAH Cooperation and Innovation Summit Forum and the Seventh Zhejiang Pharmaceutical Conference.
Classification:
Recent Events
Release time:
2023-09-18
- Meeting Time:July 21-22, 2023
- Meeting Location:Hangzhou Heda Hilton Garden Inn
- Haibu Booth:A23
- Sub-forum Two: MAH Cooperation and Innovation
- Speech Topic:"Analysis of Key Points and Case Sharing on Cooperation between B License Companies and CRO/CMO under the MAH System"
- Speech Time:July 22, 2023, 13:30-14:00
Liu ChangruBeijing Haibu Pharmaceutical,Chairman and General Manager
- EMBA from Renmin University of China, Executive Deputy Director of the R&D and Service Professional Committee of the National Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce务专业委员会 执行副主任
- 26年化学药物研发、药品注册及公司管理经验曾主持多个项目的研发和注册申报工作;取得多项
- 药物临床批件并进入临床试验，多个药品注册批件并投入生产
- 擅长研发团队人才管理的体系建设，带领团队持续进行原料药研发平台、制剂研发平台、创新平台的搭建和技术升级
北京海步医药科技有限公司（简称“海步医药”）成立于2005年，是一家以“化学药物研发”为核心能力的高新技术企业。设有北京研发中心、原料药和制剂中试验证中心、GMP工业化生产基地，主要从事原料药和制剂的CRO服务、MAH联合持证、原料药关联申报以及医药中间体商业化供应等。
在化学原料药、口服固体、液体制剂、无菌注射剂、外用制剂等多种剂型的研发转产、注册申报等方面经验丰富。研发产品涉及抗肿瘤、抗抑郁、抗癫痫、抗焦虑、心脑血管、消化系统、呼吸系统等多个适应症领域。
海步医药连续多年获得“中国医药研发公司20 强”称号，被评为北京市“专精特新”企业 、“国家高新技术企业”、“北京科技研究开发机构”、“北京亦庄企业创新中心”等。
Beijing Hope Pharmaceutical Co., Ltd.
